Centogene N.V.Centogene N.V.Centogene N.V.

Centogene N.V.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪10.32 M‬USD
−1.3707USD
‪−38.41 M‬USD
‪52.47 M‬USD
‪11.86 M‬
Beta (1Y)
2.29

About Centogene N.V.

CEO
Kim Stratton
Headquarters
Rostock
Employees (FY)
493
Founded
2018
ISIN
NL0014040206
FIGI
BBG00QKF19B3
Centogene NV is a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. It operates through the following segments: Pharmaceutical, Diagnostics, and Corporate. The Pharmaceutical segment provides solutions to pharmaceutical partners, including target discovery, early patient recruitment and identification, epidemiological insights, and biomarker discovery. The Diagnostics segment offers genetic sequencing and diagnostics services to clients, who are typically physicians, laboratories, or hospitals, either directly or through distributors. The Other segment covers COVID-19 testing services to clients. The company was founded by Arndt Rolf and Christoph Ehlers in 2006 and is headquartered in Rostock, Denmark.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CNTG is 0.3740 USD — it has decreased by 1.60% in the past 24 hours. Watch Centogene N.V. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Centogene N.V. stocks are traded under the ticker CNTG.
CNTG stock has fallen by 2.86% compared to the previous week, the month change is a 22.08% fall, over the last year Centogene N.V. has showed a 57.41% decrease.
CNTG reached its all-time high on Mar 19, 2020 with the price of 28.7109 USD, and its all-time low was 0.3457 USD and was reached on May 17, 2024. View more price dynamics on CNTG chart.
See other stocks reaching their highest and lowest prices.
CNTG stock is 5.12% volatile and has beta coefficient of 2.29. Track Centogene N.V. stock price on the chart and check out the list of the most volatile stocks — is Centogene N.V. there?
Today Centogene N.V. has the market capitalization of ‪10.32 M‬, it has decreased by 3.71% over the last week.
Yes, you can track Centogene N.V. financials in yearly and quarterly reports right on TradingView.
Centogene N.V. is going to release the next earnings report on Sep 4, 2024. Keep track of upcoming events with our Earnings Calendar.
CNTG net income for the last quarter is ‪−11.98 M‬ USD, while the quarter before that showed ‪−26.43 M‬ USD of net income which accounts for 54.67% change. Track more Centogene N.V. financial stats to get the full picture.
No, CNTG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 26, 2024, the company has 493.00 employees. See our rating of the largest employees — is Centogene N.V. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Centogene N.V. EBITDA is ‪−36.18 M‬ USD, and current EBITDA margin is −64.93%. See more stats in Centogene N.V. financial statements.
Like other stocks, CNTG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Centogene N.V. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Centogene N.V. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Centogene N.V. stock shows the sell signal. See more of Centogene N.V. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.